[Anti-IL-6 receptor antibody].
Nishimoto
Norihiro
N
Laboratory of Immune Regulation, Graduate School of Frontier Biosciences, Osaka University.
D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000502:physiology / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D001171:Arthritis, Juvenile / Q000188:drug therapy / Q000209:etiology; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000209:etiology; D005871:Castleman Disease / Q000188:drug therapy / Q000209:etiology; D003424:Crohn Disease / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D015850:Interleukin-6 / Q000502:physiology; D016032:Randomized Controlled Trials as Topic; D019947:Receptors, Interleukin-6 / Q000276:immunology* / Q000502:physiology; D016706:Still's Disease, Adult-Onset / Q000188:drug therapy / Q000209:etiology
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D015850:Interleukin-6; D019947:Receptors, Interleukin-6; C502936:tocilizumab